BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 853-859

  Wong, Michelle W ^a   Nordfors, Cecilia ^b   Mossman, David ^a   Pecenpetelovska, Gordana ^c   Avery Kiejda, Kelly A ^a   Talseth Palmer, Bente ^a   Bowden, Nikola A ^a   Scott, Rodney J ^a,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

BRIP1; Germline mutations; Hereditary breast cancer; PALB2; RAD51C

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE BRIP1; GENE PALB2; GENE RAD51C; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ADULT; AUSTRALIA; BASE SEQUENCE; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA HELICASES; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 79958282990     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1443-0     Document Type: Article

References (52)

1. HT Lynch AJ Krush 1971 Carcinoma of the breast and ovary in three families Surg Gynecol Obstet 133 4 644 648 4328854 1:STN:280: DyaE38%2FgslOntg%3D%3D
2. HT Lynch AJ Krush HM Lemon AR Kaplan PT Condit RH Bottomley 1972 Tumor variation in families with breast cancer JAMA 222 13 1631 1635 4678365 10.1001/jama.222.13.1631 1:STN:280:DyaE3s%2FkvFOrtQ%3D%3D
3. HT Lynch HA Guirgis S Albert M Brennan J Lynch C Kraft, et al. 1974 Familial association of carcinoma of the breast and ovary Surg Gynecol Obstet 138 5 717 724 4823374 1:STN:280:DyaE2c7ks1Wnsw%3D%3D
4. National breast and ovarian cancer centre. Breast Cancer. (2009); http://www.nbocc.org.au/
5. National Breast and Ovarian Cancer Centre (2009) Breast cancer risk factors: a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills, NSW
6. R Wooster BL Weber 2003 Breast and ovarian cancer NEJM 348 23 2339 2347 12788999 10.1056/NEJMra012284 1:CAS:528:DC%2BD3sXkt1Kktrc%3D (Pubitemid 36638109)
7. KL Nathanson R Wooster BL Weber 2001 Breast cancer genetics: what we know and what we need Nat Med 7 5 552 556 11329055 10.1038/87876 1:CAS:528:DC%2BD3MXjsVakurs%3D (Pubitemid 32448321)
8. MR Stratton N Rahman 2008 The emerging landscape of breast cancer susceptibility Nat Genet 40 1 17 22 18163131 10.1038/ng.2007.53 1:CAS:528:DC%2BD1cXhtVyrsQ%3D%3D
9. C Turnbull N Rahman 2008 Genetic predisposition to breast cancer: past, present and future Annu Rev Genom Hum Genet 9 321 345 10.1146/annurev.genom.9. 081307.164339 1:CAS:528:DC%2BD1cXht1SnsbbO
10. DF Easton DT Bishop D Ford GP Crockford BCL Consortium 1993 Genetic linkage analysis in familial breast and ovarian cancer Am J Hum Genet 52 4 678 701 8460634 1:CAS:528:DyaK2cXhtVemurs%3D (Pubitemid 23310135)
11. FJ Couch ML DeShano MA Blackwood K Calzone J Stopfer L Campeau, et al. 1997 BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer NEJM 336 20 1409 1415 9145677 10.1056/NEJM199705153362002 1:STN:280:DyaK2s3nsVShuw%3D%3D (Pubitemid 27208599)
12. D Ford DF Easton M Stratton S Narod D Goldgar P Devilee, et al. 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 62 676 689 9497246 10.1086/301749 1:CAS:528:DyaK1MXlvFeh (Pubitemid 28164626)
13. J Peto N Collins R Barfoot S Seal W Warren N Rahman, et al. 1999 Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer JNCI 91 11 943 949 10359546 1:CAS:528:DyaK1MXjvFOmtb4%3D (Pubitemid 29272520)
14. D Stoppa-Lyonnet P Laurent-Puig L Essioux S Pages G Ithier L Ligot Institut Curie Breast Cancer Group, et al. 1997 BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic Am J Hum Genet 60 5 1021 1030 9150149 1:CAS:528:DyaK2sXjtlOru7c%3D (Pubitemid 27194086)
15. JM Rosa-Rosa G Pita M Urioste G Llort J Brunet C Lázaro, et al. 2009 Genome-wide linkage scan reveals three putative breast-cancer susceptibility loci Am J Hum Genet 84 2 115 122 19147119 10.1016/j.ajhg.2008.12. 013 1:CAS:528:DC%2BD1MXisFCrt70%3D
16. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M et al. (2010) Genome-wide assocation study identifies five new breast cancer susceptibility loci. Nat Genet. doi: 10.1038/ng.586
17. DF Easton KA Pooley AM Dunning PD Pharoah D Thompson DG Ballinger, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 7148 1087 1093 17529967 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D (Pubitemid 47014426)
18. P Smith L McGuffog DF Easton GJ Mann GM Pupo B Newman, et al. 2006 A genome wide linkage search for breast cancer susceptibility genes Genes Chromosomes Cancer 45 7 646 655 16575876 10.1002/gcc.20330 1:CAS:528: DC%2BD28XkvFOlsbY%3D (Pubitemid 43727152)
19. B Gold T Kirchhoff S Stefanov J Lautenberger A Viale J Garber, et al. 2008 Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 Proc Natl Acad Sci USA 105 11 4340 4345 18326623 10.1073/pnas.0800441105 1:CAS:528:DC%2BD1cXktF2rs70%3D (Pubitemid 351754382)
20. DG Cox K Penney Q Guo SE Hankinson DJ Hunter 2007 TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study BMC Cancer 7 175 175 17848193 10.1186/1471-2407-7-175 (Pubitemid 350162829)
21. A Meindl H Hellebrand C Wiek V Erven B Wappenschmidt D Niederacher, et al. 2010 Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Nat Genet 42 5 410 414 20400964 10.1038/ng.569 1:CAS:528:DC%2BC3cXkvVCjtbo%3D
22. E Levy-Lahad 2010 Fanconi anemia and breast cancer susceptibility meet again Nat Genet 42 5 368 369 20428093 10.1038/ng0510-368 1:CAS:528: DC%2BC3cXlt1OlsL0%3D
23. S Seal D Thompson A Renwick A Elliott P Kelly R Barfoot, et al. 2006 Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 38 11 1239 1241 17033622 10.1038/ng1902 1:CAS:528:DC%2BD28XhtFeisbjJ (Pubitemid 44646283)
24. F Zhang Q Fan K Ren AD Auerbach PR Andreassen 2010 FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses Chromosoma 119 6 637 649 20676667 10.1007/s00412-010-0285-6 1:CAS:528:DC%2BC3cXhsVSju7nK
25. B Xia Q Sheng K Nakanishi A Ohashi J Wu N Christ, et al. 2006 Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 Mol Cell 22 6 719 729 16793542 10.1016/j.molcel.2006.05.022 1:CAS:528:DC%2BD28XmvVCitL8%3D
26. N Rahman S Seal D Thompson P Kelly A Renwick A Elliott, et al. 2007 PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 2 165 167 17200668 10.1038/ng1959 1:CAS:528:DC%2BD2sXpvFeqsw%3D%3D (Pubitemid 46184346)
27. B Xia JC Dorsman N Ameziane Y de Vries MA Rooimans Q Sheng, et al. 2007 Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 Nat Genet 39 2 159 161 17200672 10.1038/ng1942 1:CAS:528:DC%2BD2sXpvFekug%3D%3D (Pubitemid 46184344)
28. O Levran C Attwooll RT Henry KL Milton K Neveling P Rio, et al. 2005 The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia Nat Genet 37 9 931 933 16116424 10.1038/ng1624 1:CAS:528:DC%2BD2MXpsFWisbw%3D (Pubitemid 43086147)
29. F Vaz H Hanenberg B Schuster K Barker C Wiek V Erven, et al. 2010 Mutation of the RAD51C gene in a Fanconi anemia-like disorder Nat Genet 42 5 406 409 20400963 10.1038/ng.570 1:CAS:528:DC%2BC3cXkvVCjt7k%3D
30. SB Cantor DW Bell S Ganesan EM Kass R Drapkin S Grossman, et al. 2001 BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function Cell 105 1 149 160 11301010 10.1016/S0092-8674(01)00304-X 1:CAS:528:DC%2BD3MXivFOjtrg%3D (Pubitemid 32323924)
31. X Yu CC Chini M He G Mer J Chen 2003 The BRCT domain is a phospho-protein binding domain Science 302 5645 639 642 14576433 10.1126/science.1088753 1:CAS:528:DC%2BD3sXotlWqt7k%3D (Pubitemid 37310919)
32. S Cantor R Drapkin F Zhang Y Lin J Han S Pamidi, et al. 2004 The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations Proc Natl Acad Sci USA 101 8 2357 2362 14983014 10.1073/pnas.0308717101 1:CAS:528:DC%2BD2cXhvVOisLo%3D (Pubitemid 38269316)
33. SM Sy MS Huen J Chen 2009 PALB2 is an integral component of the BRCA complex required for homologous recombination repair Proc Natl Acad Sci USA 106 17 7155 7160 19369211 10.1073/pnas.0811159106 1:CAS:528:DC%2BD1MXlvVyiu7g%3D
34. S Reid D Schindler H Hanenberg K Barker S Hanks R Kalb, et al. 2007 Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer Nat Genet 39 2 162 164 17200671 10.1038/ng1947 1:CAS:528:DC%2BD2sXpvFersA%3D%3D (Pubitemid 46184345)
35. R Scully J Chen A Plug Y Xiao D Weaver J Feunteun, et al. 1997 Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 88 2 265 275 9008167 10.1016/S0092-8674(00)81847-4 1:CAS:528:DyaK2sXpsFSnuw%3D%3D (Pubitemid 28015875)
36. AR Venkitaraman 2009 Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment Annu Rev Pathol 4 461 487 18954285 10.1146/annurev.pathol.3.121806.151422 1:CAS:528:DC%2BD1MXis1ahsro%3D
37. T Ripperger D Gadzicki A Meindl B Schlegelberger 2009 Breast cancer susceptibility: current knowledge and implications for genetic counselling Eur J Hum Genet 17 6 722 731 19092773 10.1038/ejhg.2008.212 1:CAS:528: DC%2BD1MXmtFKnsLg%3D
38. M Tischkowitz B Xia N Sabbaghian JS Reis-Filho N Hamel G Li, et al. 2007 Analysis of PALB2/FANCN-associated breast cancer families PNAS 104 16 6788 6793 17420451 10.1073/pnas.0701724104 1:CAS:528:DC%2BD2sXkvFWjtrk%3D (Pubitemid 47175579)
39. JL Rutter AM Smith MR Dávila AJ Sigurdson MG Ruthann MA Pineda, et al. 2003 Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals Hum Mutat 22 2 121 128 12872252 10.1002/humu.10238 1:CAS:528:DC%2BD3sXms1Cksro%3D (Pubitemid 36950809)
40. P Kumar S Henikoff PC Ng 2009 Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm Nat Protoc 4 7 1073 1081 19561590 10.1038/nprot.2009.86 1:CAS:528:DC%2BD1MXovVyns78%3D
41. PC Ng S Henikoff 2003 SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res 31 13 3812 3814 12824425 10.1093/nar/gkg509 1:CAS:528:DC%2BD3sXltVWjs7s%3D (Pubitemid 37442253)
42. S Bamford E Dawson S Forbes J Clements R Pettett A Dogan, et al. 2004 The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website Br J Cancer 91 2 355 358 15188009 1:CAS:528:DC%2BD2cXls1ehsbo%3D (Pubitemid 39037083)
43. L Da Silva SR Lakhani 2010 Pathology of hereditary breast cancer Mod Pathol 23 Suppl 2 S46 S51 20436502 10.1038/modpathol.2010.37 1:CAS:528:DC%2BC3cXlsFWjsbs%3D
44. J Palacios E Honrado A Osorio A Cazorla D Sarrio A Barroso, et al. 2003 Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 9 10 Pt 1 3606 3614 14506147 1:CAS:528:DC%2BD3sXosVOlurc%3D (Pubitemid 37169224)
45. M Tischkowitz B Xia 2010 PALB2/FANCN: recombining cancer and Fanconi anemia Cancer Res 70 19 7353 7359 20858716 10.1158/0008-5472.CAN-10-1012 1:CAS:528:DC%2BC3cXht1akt7zI
46. WD Foulkes P Ghadirian MR Akbari N Hamel S Giroux N Sabbaghian, et al. 2007 Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women Breast Cancer Res 9 6 83 10.1186/bcr1828
47. AW Oliver S Swift CJ Lord A Ashworth LH Pearl 2009 Structural basis for recruitment of BRCA2 by PALB2 EMBO Rep 10 9 990 996 19609323 10.1038/embor.2009.126 1:CAS:528:DC%2BD1MXoslentbw%3D
48. F Zhang Q Fan K Ren PR Andreassen 2009 PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2 Mol Cancer Res 7 7 1110 1118 19584259 10.1158/1541-7786.MCR-09-0123 1:CAS:528:DC%2BD1MXos1emtrc%3D
49. F Zhang J Ma J Wu L Ye H Cai B Xia, et al. 2009 PALB2 links BRCA1 and BRCA2 in the DNA-damage response Curr Biol 19 6 524 529 19268590 10.1016/j.cub.2009.02.018 1:CAS:528:DC%2BD1MXjsFWrtbk%3D
50. R Buisson AM Dion-Cote Y Coulombe H Launay H Cai AZ Stasiak, et al. 2010 Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination Nat Struct Mol Biol 17 10 1247 1254 20871615 10.1038/nsmb.1915 1:CAS:528:DC%2BC3cXht1Slur%2FF
51. D Thompson DF Easton 2002 Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 18 1358 1365 12237281 1:CAS:528:DC%2BD38Xnt1Gnurs%3D (Pubitemid 35154140)
52. The Breast Cancer Linkage Consortium 1999 Cancer risks in BRCA2 mutation carriers JNCI 91 15 1310 1316